Characterization of white matter over 1-2 years in small vessel disease using MR-based quantitative susceptibility mapping and free-water mapping

被引:4
|
作者
Sun, Yawen [1 ]
Hu, Ying [1 ]
Qiu, Yage [1 ]
Zhang, Yuyao [2 ]
Jiang, Changhao [2 ]
Lu, Peiwen [3 ,4 ]
Xu, Qun [3 ,4 ,5 ]
Shi, Yuting [6 ]
Wei, Hongjiang [6 ]
Zhou, Yan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
[2] ShanghaiTech Univ, Sch Informat & Sci & Technol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Ren Ji Hosp, Ren Ji UNSW CHeBA Neurocognit Ctr, Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Hlth, Sch Med,Manage Ctr, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
small vessel disease; quantitative susceptibility mapping; free-water mapping; white matter lesions; normal-appearing white matter; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; STROKE; HYPERINTENSITIES; PROGRESSION; INTEGRITY; DEMENTIA; MODEL;
D O I
10.3389/fnagi.2022.998051
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
PurposeThe aim of this study was to investigate alterations in white matter lesions (WMLs) and normal-appearing white matter (NAWM) with small vessel disease (SVD) over 1-2 years using quantitative susceptibility mapping (QSM) and free-water (FW) mapping. MethodsFifty-one SVD patients underwent MRI brain scans and neuropsychological testing both at baseline and follow-up. The main approach for treating these patients is the management of risk factors. Quantitative susceptibility (QS), fractional anisotropy (FA), mean diffusivity (MD), FW, FW-corrected FA (FA(T)), and FW-corrected MD (MDT) maps within WMLs and NAWM were generated. Furthermore, the JHU-ICBM-DTI label atlas was used as an anatomic guide, and the measurements of the segmented NAWMs were calculated. The average regional values were extracted, and a paired t-test was used to analyze the longitudinal change. Partial correlations were used to assess the relationship between the MRI indices changes (e.g., Delta QS(followup - baseline)/QS(baseline)) and the cognitive function changes (e.g., Delta MoCA(followup - baseline)/MoCA(baseline)). ResultsAfter SVD risk factor control, no gradual cognitive decline occurred during 1-2 years. However, we still found that the QS values (index of demyelination) increased in the NAWM at follow-up, especially in the NAWM part of the left superior frontal blade (SF), left occipital blade, right uncinate fasciculus, and right corticospinal tract (CST). FW (index of neuroinflammation/edema) analysis revealed that the follow-up group differed from the baseline group in the NAWM part of the right CST and inferior frontal blade (IF). Decreased FA(T) (index of axonal loss) was observed in the NAWM part of the right SF and IF at follow-up. In addition, the FA(T) changes in the NAWM part of the right IF were associated with overall cognitive performance changes. In contrast, no significant differences were found in the WMLs. ConclusionThe NAWM was still in the progressive injury process over time, while WMLs remained relatively stable, which supports the notion that SVD is a chronic progressive disease. The process of axonal loss in the NAWM part of the prefrontal lobe might be a biomarker of cognitive changes in the evolution of SVD.
引用
收藏
页数:13
相关论文
共 24 条
  • [21] Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping
    Kim, Hyug-Gi
    Park, Soonchan
    Rhee, Hak Y.
    Lee, Kyung M.
    Ryu, Chang-Woo
    Lee, Soo Y.
    Kim, Eui J.
    Wang, Yi
    Jahng, Geon-Ho
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (05) : 428 - 437
  • [22] Differentiating the dopaminergic midbrain nuclei in early-stage Parkinsons disease using quantitative susceptibility mapping and R2*relaxometry (P1-1.Virtual)
    Alushaj, Erind
    Handfield-Jones, Nicholas
    Kuurstra, Alan
    Menon, Ravi
    Owen, Adrian
    Khan, Ali
    MacDonald, Penny
    NEUROLOGY, 2022, 98 (18)
  • [23] Correlation between matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 and white matter hyperintensities in patients with cerebral small vessel disease based on cranial magnetic resonance 3D imaging
    Luo, Beilin
    He, Shunpo
    Zhang, Yifen
    Yang, Qingwei
    Zhuang, Jingcong
    Zhu, Renjing
    Zheng, Yuqing
    Su, Huamei
    CEREBROVASCULAR DISEASES, 2024, 53 : 136 - 136
  • [24] Correlation between matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 and white matter hyperintensities in patients with cerebral small vessel disease based on cranial magnetic resonance 3D imaging
    Luo, Bei-Lin
    He, Shun-Po
    Zhang, Yi-Fen
    Yang, Qing-Wei
    Zhuang, Jing-Cong
    Zhu, Ren-Jing
    Zheng, Ya-Qin
    Su, Hua-Mei
    MAGNETIC RESONANCE IMAGING, 2024, 113